Pcj Investment Counsel Ltd. Profound Medical Corp. Transaction History

Pcj Investment Counsel Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$8.16 - $11.33 $3,272 - $4,543	-401 Reduced 0.36%	110,999 $998,000
Q4 2021 Feb 10, 2022	SELL	$10.38 - $15.2 $280,986 - $411,464	-27,070 Reduced 19.55%	111,400 $1.26 Million
Q3 2021 Nov 10, 2021	SELL	$13.6 - $17.88 $363,800 - $478,290	-26,750 Reduced 16.19%	138,470 $2.02 Million
Q2 2021 Aug 02, 2021	BUY	$16.0 - $20.59 $319,840 - $411,594	19,990 Added 13.76%	165,220 $2.69 Million
Q1 2021 Apr 30, 2021	BUY	$19.16 - $28.09 $350,628 - $514,047	18,300 Added 14.42%	145,230 $2.91 Million
Q4 2020 Feb 10, 2021	BUY	$16.4 - $22.9 $88,067 - $122,972	5,370 Added 4.42%	126,930 $2.61 Million
Q3 2020 Nov 12, 2020	BUY	$14.05 - $18.13 $413,632 - $533,747	29,440 Added 31.96%	121,560 $2.14 Million
Q2 2020 Aug 13, 2020	SELL	$9.41 - $16.94 $21,643 - $38,962	-2,300 Reduced 2.44%	92,120 $1.56 Million
Q1 2020 May 13, 2020	BUY	$6.88 - $19.7 $649,609 - $1.86 Million	94,420 New	94,420 $909,000

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $157M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Pcj Investment Counsel Ltd., based on Form 13F filings with the SEC.

Stay updated on Pcj Investment Counsel Ltd. with notifications on news.